OCYTLA

Welcome to the Brand page for “OCYTLA”, which is offered here for Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; pharmaceutical preparations and substances, antibodies; vaccines;.

Its status is currently believed to be active. Its class is unavailable. “OCYTLA” is believed to be currently owned by “ASTRAZENECA AB”.